Adequan® i.m.INDICATIONSFor the intramuscular treatment of non-infectious degenerative and/or
traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.IMPORTANT SAFETY INFORMATIONStudies have not been conducted to establish safety in breeding horses.
WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
BetaVet®INDICATIONSBetaVet® is indicated for the control of pain and inflammation associated with osteoarthritis in horses.IMPORTANT SAFETY INFORMATIONFor Intra-articular (I.A.) use in Horses.
CONTRAINDICATIONS:BetaVet® is contraindicated in horses with hypersensitivity to betamethasone. Intra-articular injection of corticosteroids
for local effect is contraindicated in the presence of septic arthritis.WARNINGS: Do not use in horses intended for human consumption.Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the
first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia,
fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have
resulted in cleft palate in offspring and in other congenital anomalies including deformed forelegs, phocomelia and anasarca. Therefore,
before use of corticosteroids in pregnant animals, the possible benefits to the pregnant animal should be weighed against potential
hazards to its developing embryo or fetus. Human Warnings: Not for use in humans. For use in animals only. Keep this and all medications
out of the reach of children. Consult a physician in the case of accidental human exposure. PRECAUTIONS:Corticosteroids, including BetaVet®, administered intra-articularly are systemically absorbed. Do not use in horses with
acute infections. Acute moderate to severe exacerbation of pain, further loss of joint motion, fever, or malaise within several days following
intra-articular injection may indicate a septic process. Because of the anti-inflammatory action of corticosteroids, signs of infection in the
treated joint may be masked. Due to the potential for exacerbation of clinical signs of laminitis, glucocorticoids should be used with caution
in horses with a history of laminitis, or horses otherwise at a higher risk for laminitis. Use with caution in horses with chronic nephritis,
equine pituitary pars intermedia dysfunction (PPID), and congestive heart failure. Concurrent use of other anti-inflammatory drugs, such as
NSAIDs or other corticosteroids, should be approached with caution. Due to the potential for systemic exposure, concomitant use of NSAIDs
and corticosteroids may increase the risk of gastrointestinal, renal, and other toxicity. Consider appropriate wash out times prior to
administering additional NSAIDs or corticosteroids. ADVERSE REACTIONS: Adverse reactions reported during a field study of 239 horses of various breeds which had been administered
either BetaVet® (n=119) or a saline control (n=120) at five percent (5%) and above were: acute joint effusion and/or local injection site
swelling (within 2 days of injection), 15% BetaVet® and 13% saline control; increased lameness (within the first 5 days), 6.7% BetaVet®
and 8.3% saline control; loose stool, 5.9% BetaVet® and 8.3% saline control; increased heat in joint, 2.5% BetaVet® and 5% saline control;
and depression, 5.9% BetaVet® and 1.6% saline control. DOSAGE AND ADMINISTRATION: Shake well immediately before use. Use immediately after opening, then discard any remaining contents.
Use immediately after opening, then discard any remaining contents. RX ONLY